PSS14 COST-EFFECTIVENESS OF THE TREATMENT FOR MODERATE TO SEVERE PSORIASIS IN MEXICO- INFLIXIMAB, ETANERCEPT AND EFALIZUMAB
May 1, 2008, 00:00
10.1016/S1098-3015(10)70909-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)70909-8/fulltext
Title :
PSS14 COST-EFFECTIVENESS OF THE TREATMENT FOR MODERATE TO SEVERE PSORIASIS IN MEXICO- INFLIXIMAB, ETANERCEPT AND EFALIZUMAB
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70909-8&doi=10.1016/S1098-3015(10)70909-8
First page :
Section Title :
Open access? :
No
Section Order :
664